-
Symbol
-
LENZ on Nasdaq
-
Investment type
-
Equity / Common Stock, $0.00001 par value per share
-
Latest Disclosed Ownership
-
1.05M shares
-
Security Ownership
-
3.4%
Versant Venture Capital VI, L.P. ownership in LENZ Therapeutics, Inc. Common Stock, $0.00001 par value per share (LENZ)
2025-11-10 - Versant Venture Capital VI, L.P. has filed an SCHEDULE 13D/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 1.05M shares of LENZ Therapeutics, Inc. Common Stock, $0.00001 par value per share (LENZ).
This represents 3.4% percent ownership of the company.
In their previous filing dated 2025-09-22, Versant Venture Capital VI, L.P. had reported owning 1.18M shares, indicating a decrease of -11.2% percent.